Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the multiomics market?

The market size of multiomics has seen substantial growth in the recent past. The market is expected to expand from a valuation of $3.27 billion in 2024 to $3.85 billion in 2025, registering a compound annual growth rate (CAGR) of 17.9%. The growth trajectory in the historical period is largely due to factors such as an upsurge in biomedical research, more funding from private and government sectors, higher prevalence of chronic diseases, advancements in technology, and improved computational tools and software for data examination.

What will be the multiomics market size in the future?

The size of the multiomics market is projected to witness a significant spike in the coming years. With a compound annual growth rate (CAGR) of 17.6%, it is expected to reach $7.38 billion in 2029. The anticipated growth during the forecast period can be credited to the advancements made in areas of artificial intelligence and machine learning, the broadening scope of clinical applications, the expanding biopharmaceutical industry, the introduction of collaborative multiomics platforms, and their widening utilization in agriculture and environmental research. Key trends for the forecast period encompass technological progress, the introduction of new multiomics platforms in the commercial market, wider adoption of spatially resolved multiomics analysis, increased usage in biopharmaceutical R&D, and their proliferation into the realm of clinical diagnostics.

Get your multiomics market report here!

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

What main drivers are fueling expansion in the multiomics market?

The growth of the multiomics market is anticipated to surge due to the increasing demand for personalized medicine. Personalized medicine is a medical strategy designed to cater healthcare decisions and treatments to patients individually with consideration to their genetic, environmental, and lifestyle aspects. The surge in personalized medicine is a result of technological advancements, a growing appetite for targeted therapies, and global improvements in healthcare. Multiomics contributes to personalized medicine by giving an in-depth comprehension of someone’s genetic, molecular, and metabolic makeup, thereby empowering healthcare providers to tailor treatments based on the unique characteristics of each patient. For instance, the Personalized Medicine Coalition, a non-profit organization based in the U.S., declared in February 2024 that the FDA had greenlighted 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from 6 in 2022. As such, the growing demand for personalized medicine plays a significant role in boosting the multiomics market.

What key areas define the segmentation of the global multiomics market?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

Who are the dominant players expanding their reach in the multiomics market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

What key trends are currently impacting the multiomics market’s development?

Dominant businesses in the multiomics sector are innovating by creating advanced single-cell multiomics platforms, providing the scientific community the ability to perform large-scale experiments without compromising on sample integrity. These single-cell multiomics tools amalgamate various omics data and use artificial intelligence to simplify the analysis and understanding of complex biological information, with the help of intricate algorithms and machine learning methodologies. As an example, Becton, Dickinson, and Company, a medical device firm from the US, unveiled the BD Rhapsody HT Xpress in February 2023. This is a high-throughput single-cell multiomics platform designed to allow scientists to isolate, barcode, and analyze individual cells on a larger scale, facilitating analysis of up to eight times more cells in comparison to older models of BD single-cell analyzers. This state-of-the-art BD Rhapsody HT Xpress System ensures zero sample loss and provides flexibility to simultaneously analyze various samples, different cell sizes, and types such as stem cells or cancer cells. This significantly bolsters the capability of researchers to derive more in-depth insights in a shorter span.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

Which regions are emerging as leaders in the multiomics market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Multimode-Fiber Cable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Multiwall Bags Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiwall-bags-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: